Sanjay Bhagani

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Immune Remodeling in People Living with HIV/HBV Co-Infection on Long-Term Therapy: Revisiting the Paradigm of Additive Dysfunction [Letter].

Use of dual ART in individuals with different HBV serological patterns.

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with HIV.

Comparing short-term mortality between people with and without HIV admitted to the intensive care unit: A single-centre matched cohort study (2000-2019).

Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials.

International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreak.

Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Sofosbuvir as post-exposure prophylaxis for yellow fever-associated viscerotropic disease (YEL-AVD).

Severe acute respiratory syndrome coronavirus-2 antibody prevalence in adults with HIV.

Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019.

Correction to: Sofosbuvir as post-exposure prophylaxis for yellow fever-associated viscerotropic disease (YEL-AVD).

First-Line Switch to B/F/TAF for Treatment of HIV in Older Adults ≥60 Years in Kenya (the B/F/TAF-Elderly Study).

Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.

Knowledge about biomedical HIV prevention among healthcare workers: A cross-sectional study in Europe and Central Asia.

Protocol for a core outcome set for pharmacological treatments in hospitalised patients with acute viral respiratory infections (COSAVRI).

Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease.

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses.

The role of gut barrier dysfunction in postoperative complications in liver transplantation: pathophysiological and therapeutic considerations.

High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with <scp>HIV</scp>

Metabolic dysfunction-associated steatohepatitis exhibits sex differences in people with HIV.

Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.

Gender and ethnicity intersect to reduce participation at a large European hybrid HIV conference.

Elimination of perinatal transmission of hepatitis B: lessons learned from women with HIV-HBV coinfection.

Improving 1-Year Mortality Following Intensive Care Unit Admission in Adults with HIV: A 20-Year Observational Study.

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.